GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Total duration:
3 h 06 min
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:02
Barriers to Biomarker Testing: Cost and Insurance
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:30
Barriers to Biomarker Testing: Ordering Tests
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
06:23
The Adaura Trial: The Effect on EGFR+ Treatment
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
06:26
Biomarker Driven Therapy for NSCLC
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
05:13
Current Recommendations and Best Practices for Biomarker Testing
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:53
The Importance of Biomarker Testing: What is Liquid Biopsy?
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
04:55
Biomarkers in NSCLC
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
05:55
Key Points from the Adaura Trial: Osimertinib
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
06:14
Biomarkers in NSCLC
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
05:55
The Importance of Biomarker Testing: What is Liquid Biopsy?
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
04:55
Barriers to Biomarker Testing: Cost and Insurance
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:30
Neoadjuvant Treatment for Patients with NSCLC
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:11
The Alina Trial for ALK+ NSCLC
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
01:13
Local Therapy for Limited Metastatic NSCLC
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
04:17
Immunotherapy for Patients with Resectable NSCLC and a Driver Mutation
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
02:05
Treatment Options for Patients with Locally Advanced Unresectable NSCLC
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
01:59
Local Therapy for NSCLC Patients After Frontline Therapy
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
07:52
The Role of the Patient as Advocate
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
02:59
Targeted Therapy Before Surgery in Patients with Resectable NSCLC and Driver Mutation
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:12
Local Therapy for Patients with Oligoprogressive NSCLC
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
05:27
The Future of Local Therapy in Lung Cancer
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
02:55
Adding to Targeted Therapy: Current Statistics and Biology
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
05:17
The Importance of Prostate Cancer Screening
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:45
सामान्य परामर्श मुद्दे (Common Consultation Issues)
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:52
पुरुषत्वीकरण चिकित्सा और द्वितीय एरिथ्रोसाइटोसिस (Masculinizing Therapy and Secondary Erythrocytosis)
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
08:01
सिकल सेल रोग और जेंडर अफर्मिंग हार्मोन थेरेपी (Sickle Cell Disease and Gender Affirming Hormone Therapy)
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:09
फेमिनाइजिंग थेरेपी और थ्रोम्बोसिस (Feminizing Therapy and Thrombosis)
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
09:37
भारत में ट्रांसजेंडर मुद्दे (Transgender Issues in India)
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:05
Neoadjuvant Therapy in Melanoma: Does It Give a Better Immune Response?
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
05:36
Neoadjuvant Therapy for Melanoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
07:26
Adjuvant Therapy for Melanoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:14
Adjuvant Therapy in Stage 3 and 4 Melanoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
05:42
Patient Selection for First Line Therapy in Stage 4 Melanoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
06:00
Neoadjuvant Therapy in Melanoma: The PRADO Trial
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:48
Major Advances in Uveal Melanoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:33
Clinical Trials in Melanoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
04:38
Incidence Trends in Melanoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
04:24
Side Effects of Immunotherapy in Melanoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
03:54
Treatment for Metastatic Melanoma
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
06:05